APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,222,440 | +1.9% | 111,000 | +144.0% | 0.67% | +16.0% |
| Q2 2023 | $4,144,595 | -26.5% | 45,495 | -46.8% | 0.58% | -26.9% |
| Q1 2023 | $5,640,240 | +95.8% | 85,510 | +53.5% | 0.79% | +100.3% |
| Q4 2022 | $2,879,988 | -78.6% | 55,695 | -71.8% | 0.39% | -78.2% |
| Q3 2022 | $13,475,000 | +130.1% | 197,290 | +52.3% | 1.80% | +126.7% |
| Q2 2022 | $5,856,000 | +130.3% | 129,508 | +158.8% | 0.80% | +178.0% |
| Q1 2022 | $2,543,000 | -48.0% | 50,040 | -51.6% | 0.29% | -59.6% |
| Q4 2021 | $4,890,000 | -35.2% | 103,425 | -13.4% | 0.71% | -24.3% |
| Q2 2021 | $7,549,000 | -2.2% | 119,445 | -11.5% | 0.94% | -12.5% |
| Q4 2020 | $7,719,000 | +917.0% | 134,945 | +376.0% | 1.07% | +325.5% |
| Q1 2020 | $759,000 | – | 28,350 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |